过去一年中添加的文章,按日期排序
… the co-culture of human amniotic fluid-derived mesenchymal stem cells with peripheral blood mononuclear cells differs between type 1 diabetes mellitus patients and …
SM Hoseini, F Moghimi, ES Hosseini, SM Miresmaeili… - 2023 - europepmc.org
239 天前 - … -1 ), chemokine ligands ( CCL3 , CXCL9, CXCL10 ) and receptors involved in immune
cell trafficking ( CXCR3 … genes, including CXCR3 and its ligands ( CXCL9 and CXCL10 ), …
cell trafficking ( CXCR3 … genes, including CXCR3 and its ligands ( CXCL9 and CXCL10 ), …
… paracrine and cell contact effects of human amniotic fluid-derived mesenchymal stem cells on peripheral blood mononuclear cells of type 1 diabetes patients imply the …
SM Hoseini, F Moghimi, ES Hosseini, SM Miresmaeili… - 2023 - researchsquare.com
259 天前 - … -1), chemokine ligands (CCL3, CXCL9, CXCL10) and receptors involved in immune
cell trafficking (CXCR3, … genes, including CXCR3 and its ligands (CXCL9 and CXCL10), …
cell trafficking (CXCR3, … genes, including CXCR3 and its ligands (CXCL9 and CXCL10), …
Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine
S Pöysti, S Silojärvi, TC Brodnicki, T Catterall… - Journal of …, 2023 - Elsevier
281 天前 - … CXCL10 is an IFNγ-inducible chemokine implicated in the pathogenesis of type 1
diabetes. T-… The necessity of the CXCR3/CXCL10 axis in diabetes development was also …
diabetes. T-… The necessity of the CXCR3/CXCL10 axis in diabetes development was also …
… of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes
U Christen, L Pouzol, M Tunis, A Sassi… - Clinical and …, 2023 - academic.oup.com
305 天前 - … type 1 diabetes animal models and human pancreatic organ donors with recent-onset
type 1 diabetes identified CXCL9 and CXCL10 … chemokine receptor CXCR3 to pancreatic …
type 1 diabetes identified CXCL9 and CXCL10 … chemokine receptor CXCR3 to pancreatic …
相关搜索
- persistent remission type 1 diabetes
- stem cells type 1 diabetes
- cxcr3 antagonist type 1 diabetes
- expression in type 1 diabetes
- type 1 diabetes model
- mice with type 1 diabetes
- cxc motif type 1 diabetes
- impact of type 2 diabetes mellitus
- type 1 diabetes mellitus patients
- treatment of type 2 diabetes
- immune alternations type 1 diabetes
- autologous mesenchymal type 1 diabetes
- therapeutic outcomes type 1 diabetes
- study protocol type 1 diabetes
- immune response type 1 diabetes
- islet isografts type 1 diabetes